港通医疗 reported revenue of ¥0.27B for the period ended 2026-06-30, +2.8% year on year. Net income was ¥-0.02B, a -7.3% net margin on a 16.8% gross margin. The largest revenue line is 医用洁净装备及系统 at 63% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.27B | +2.8% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 16.8% | Net margin -7.3% |
| Revenue Q/Q | +339.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 医用洁净装备及系统 | ¥0.17B | 63.0% |
| 医用气体装备及系统 | ¥0.08B | 30.0% |
| 医疗设备及其他产品销售 | ¥0.01B | 4.7% |
| 运维服务 | ¥0.01B | 2.1% |
| 其他(补充) | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 83.2% |
| R&D | ¥0.01B | 3.7% |
| SG&A | ¥0.04B | 14.5% |
| Tax & other | ¥-0.00B | -1.8% |
| Item | Amount |
|---|---|
| Total assets | ¥2.09B |
| Total liabilities | ¥0.88B |
| Shareholders' equity | ¥1.21B |
| Equity / assets | 57.7% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | 228% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技 ・ 春光集团 ・ 威马农机
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies